Soy isoflavones improve cardiovascular disease risk markers in women during the early menopause

Hormone replacement therapy may be beneficial for cardiovascular disease risk (CVR) in post-menopausal women. Soy isoflavones may act as selective estrogen receptor modulators. The aim of this study was to evaluate whether soy isoflavones had an effect on CVR markers.

Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - April 9, 2018 Category: Nutrition Authors: Thozhukat Sathyapalan, Myint Aye, Alan S. Rigby, Natalie J. Thatcher, Soha R. Dargham, Eric S. Kilpatrick, Stephen L. Atkin Source Type: research